
An immunodepletion procedure advances free angiopoietin-2 determination in human plasma samples during anti-cancer therapy with bispecific anti-Ang2/VEGF CrossMab
Keywords: Ang2; angiopoietin-2; anti-A2V; anti-Ang2/VEGF-CrossMab; anti-Id; anti-idiotypic; mAb; monoclonal antibody; VEGF-A; vascular endothelial growth factor-A; SA; streptavidin; Bispecific therapeutic antibody; Immunodepletion; Free target quantification; Total